Pharmaceutical Drug Development Services Market: By Molecule Type (Biological Solutions, Small Molecule Solutions, and Biosimilar Development Solutions), By Phase (Pre-Clinical, Phase I, Phase II, Phase III), By Specialty Area (Cardiovascular, Diabetes, Endocrinology, Nephrology, Immuno-Oncology, Infectious Diseases, Oncology, Rare Diseases and Orphan Drugs, Pediatrics, Neuroscience, and Others) and Geography

   

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Pharmaceutical Drug Development Services Market size was valued at USD x million in 2021 and is expected to reach USD x million by 2028, at a CAGR of x% during the forecast period 2022 to 2028. Owing to increasing stringent regulatory framework and cost of drug development for products coupled with focus of the pharmaceutical and biopharmaceutical companies on CROs and CDMOs to reduce the cost of the development of the product are the major factors that are driving the growth of the pharmaceutical drug development services market. Moreover, Identification of lead, drug discovery, clinical trial monitoring and regulatory compliance fuels the growth of the market over the forecast period. This report studies global pharmaceutical drug development services market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global pharmaceutical drug development services market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global pharmaceutical drug development services market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities).

Pharmaceutical Drug Development Services Market Summary

Study Period

2023-29

Base Year

2022

CAGR

x%

Largest Market

Asia-Pacific

Fastest Growing Market

North-America
Pharmaceutical Drug Development Services Market

The pharmaceutical and biopharmaceutical companies are focusing on the strategic collaborations with the drug development service providers to avoid the stringent regulatory policies and to reduce the cost of the drug development and this is the trend that was being observed in the market. For instance, in June 2018, Syneos Health and Elligo Health Research entered into a strategic collaboration to mobilize a system of accelerated research to reach real-world patients.

Key Features of the Reports

  • Global pharmaceutical drug development services market expanding at significant CAGR over 2019 to 2025 owing to increasing demand for outsourcing to the CROs and CDMOs for drug development services.
  • Based on specialty area, oncology segment of pharmaceutical drug development services accounted for larger market revenue share in 2018 and projected gain market revenue share over the forecast period
  • Players focusing on collaboration strategies with the government to retain market position in global pharmaceutical drug development services market

Pharmaceutical Drug Development Services Market Segmentation

By Molecule Type
  • Biologic Solutions
  • Small Molecule Solutions
  • Biosimilar Development Solutions
By Phase
  • Pre-Clinical
  • Phase I
  • Phase II
  • Phase III
By Specialty Area
  • Cardiovascular
  • Diabetes, Endocrinology, and Nephrology
  • Immuno-Oncology
  • Infectious Diseases
  • Oncology
  • Rare Diseases and Orphan Drugs
  • Pediatrics
  • Neuroscience
  • Others

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

  1. Executive Summary
  2. Global Pharmaceutical Drug Development Services Market Introduction
2.1. Global Pharmaceutical Drug Development Services Market – Taxonomy 2.2. Global Pharmaceutical Drug Development Services Market –Definitions 2.2.1. By Molecule 2.2.2. By Phase 2.2.3. By Specialty Type
  1. Global Pharmaceutical Drug Development Services Market Dynamics
3.1. Drivers 3.2. Restraints 3.3. Opportunities/Unmet Needs of the Market 3.4. Trends 3.5. Global Pharmaceutical Drug Development Services Market Dynamics – Factors Impact Analysis
  1. Global Pharmaceutical Drug Development Services Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
4.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn) 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 4.3. Market Opportunity Analysis
  1. Global Pharmaceutical Drug Development Services Market Forecast, By Molecule, 2014 - 2018 and Forecast, 2019 - 2025
5.1. Biologic Solutions 5.1.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn) 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.1.3. Market Opportunity Analysis 5.2. Small Molecule Solutions 5.2.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn) 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.2.3. Market Opportunity Analysis 5.3. Biosimilar Development Solutions 5.3.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn) 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.3.3. Market Opportunity Analysis
  1. Global Pharmaceutical Drug Development Services Market Forecast, By Phase, 2014 - 2018 and Forecast, 2019 - 2025
6.1. Pre-Clinical 6.1.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn) 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 6.1.3. Market Opportunity Analysis 6.2. Phase 1 6.2.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn) 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 6.2.3. Market Opportunity Analysis 6.3. Phase II 6.3.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn) 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 6.3.3. Market Opportunity Analysis 6.4. Phase III 6.4.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn) 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 6.4.3. Market Opportunity Analysis
  1. Global Pharmaceutical Drug Development Services Market Forecast, By Specialty Type, 2014 - 2018 and Forecast, 2019 - 2025
7.1. Cardiovascular 7.1.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn) 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.1.3. Market Opportunity Analysis 7.2. Diabetes, Endocrinology, and Nephrology 7.2.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn) 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.2.3. Market Opportunity Analysis 7.3. Immuno-Oncology 7.3.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn) 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.3.3. Market Opportunity Analysis 7.4. Infectious Diseases 7.4.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn) 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.4.3. Market Opportunity Analysis 7.5. Oncology 7.5.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn) 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.5.3. Market Opportunity Analysis 7.6. Rare Diseases and Orphan Drugs 7.6.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn) 7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.6.3. Market Opportunity Analysis 7.7. Pediatrics 7.7.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn) 7.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.7.3. Market Opportunity Analysis 7.8. Neuroscience 7.8.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn) 7.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.8.3. Market Opportunity Analysis 7.9. Others 7.9.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn) 7.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.9.3. Market Opportunity Analysis
  1. Global Pharmaceutical Drug Development Services Market Forecast, By Region, 2014 - 2018 and Forecast, 2019 - 2025
8.1. North America 8.1.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn) 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 8.1.3. Market Opportunity Analysis 8.2. Europe 8.2.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn) 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 8.2.3. Market Opportunity Analysis 8.3. Asia Pacific 8.3.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn) 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 8.3.3. Market Opportunity Analysis 8.4. Latin America 8.4.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn) 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 8.4.3. Market Opportunity Analysis 8.5. The Middle East & Africa 8.5.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn) 8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 8.5.3. Market Opportunity Analysis 8.6. Global Pharmaceutical Drug Development Services Market - Opportunity Analysis Index, By Product, By Application, By End User, and Region, 2019 - 2025
  1. North America Pharmaceutical Drug Development Services Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
9.1. Molecule Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 9.1.1. Biologic Solutions 9.1.2. Small Molecule Solutions 9.1.3. Biosimilar Development Solutions 9.2. Phase Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 9.2.1. Pre-Clinical 9.2.2. Phase I 9.2.3. Phase II 9.2.4. Phase III 9.3. Specialty Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 9.3.1. Cardiovascular 9.3.2. Diabetes, Endocrinology, and Nephrology 9.3.3. Immuno-Oncology 9.3.4. Infectious Diseases 9.3.5. Oncology 9.3.6. Rare Diseases and Orphan Drugs 9.3.7. Pediatrics 9.3.8. Neuroscience 9.3.9. Others 9.4. Country Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 9.4.1. U.S. 9.4.2. Canada 9.5. North America Pharmaceutical Drug Development Services Market - Opportunity Analysis Index, By Molecule Type, By Phase, By Specialty Type, and Country, 2019 - 2025 9.6. North America Pharmaceutical Drug Development Services Market Dynamics – Trends
  1. Europe Pharmaceutical Drug Development Services Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
10.1. Molecule Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 10.1.1. Biologic Solutions 10.1.2. Small Molecule Solutions 10.1.3. Biosimilar Development Solutions 10.2. Phase Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 10.2.1. Pre-Clinical 10.2.2. Phase I 10.2.3. Phase II 10.2.4. Phase III 10.3. Specialty Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 10.3.1. Cardiovascular 10.3.2. Diabetes, Endocrinology, and Nephrology 10.3.3. Immuno-Oncology 10.3.4. Infectious Diseases 10.3.5. Oncology 10.3.6. Rare Diseases and Orphan Drugs 10.3.7. Pediatrics 10.3.8. Neuroscience 10.3.9. Others 10.4. Country Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 10.4.1. U.K. 10.4.2. Germany 10.4.3. France 10.4.4. Italy 10.4.5. Spain 10.4.6. Russia 10.4.7. Rest of Europe 10.5. Europe Pharmaceutical Drug Development Services Market - Opportunity Analysis Index, By Molecule, By Phase, By Specialty Type, and Country, 2019 - 2025 10.6. Europe Pharmaceutical Drug Development Services Market Dynamics – Trends
  1. Asia Pacific Pharmaceutical Drug Development Services Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
11.1. Molecule Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 11.1.1. Biologic Solutions 11.1.2. Small Molecule Solutions 11.1.3. Biosimilar Development Solutions 11.2. Phase Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 11.2.1. Pre-Clinical 11.2.2. Phase I 11.2.3. Phase II 11.2.4. Phase III 11.3. Specialty Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 11.3.1. Cardiovascular 11.3.2. Diabetes, Endocrinology, and Nephrology 11.3.3. Immuno-Oncology 11.3.4. Infectious Diseases 11.3.5. Oncology 11.3.6. Rare Diseases and Orphan Drugs 11.3.7. Pediatrics 11.3.8. Neuroscience 11.3.9. Others 11.4. Country Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 11.4.1. China 11.4.2. Japan 11.4.3. India 11.4.4. ASEAN Counties 11.4.5. Philippines 11.4.6. Rest of Asia Pacific 11.5. Asia Pacific Pharmaceutical Drug Development Services Market - Opportunity Analysis Index, By Molecule, By Phase, By Specialty Type, and Country, 2019 - 2025 11.6. Asia Pacific Pharmaceutical Drug Development Services Market Dynamics – Trends
  1. Latin America Pharmaceutical Drug Development Services Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
12.1. Molecule Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 12.1.1. Biologic Solutions 12.1.2. Small Molecule Solutions 12.1.3. Biosimilar Development Solutions 12.2. Phase Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 12.2.1. Pre-Clinical 12.2.2. Phase I 12.2.3. Phase II 12.2.4. Phase III 12.3. Specialty Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 12.3.1. Cardiovascular 12.3.2. Diabetes, Endocrinology, and Nephrology 12.3.3. Immuno-Oncology 12.3.4. Infectious Diseases 12.3.5. Oncology 12.3.6. Rare Diseases and Orphan Drugs 12.3.7. Pediatrics 12.3.8. Neuroscience 12.3.9. Others 12.4. Country Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 12.4.1. Mexico 12.4.2. Brazil 12.4.3. Argentina 12.4.4. Chile 12.4.5. Rest of Latin America 12.5. Latin America Pharmaceutical Drug Development Services Market - Opportunity Analysis Index, By Molecule, By Phase, By Specialty Type, and Country, 2019 - 2025 12.6. Latin America Pharmaceutical Drug Development Services Market Dynamics – Trends
  1. Middle East and Africa Pharmaceutical Drug Development Services Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
13.1. Molecule Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 13.1.1. Biologic Solutions 13.1.2. Small Molecule Solutions 13.1.3. Biosimilar Development Solutions 13.2. Phase Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 13.2.1. Pre-Clinical 13.2.2. Phase I 13.2.3. Phase II 13.2.4. Phase III 13.3. Specialty Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 13.3.1. Cardiovascular 13.3.2. Diabetes, Endocrinology, and Nephrology 13.3.3. Immuno-Oncology 13.3.4. Infectious Diseases 13.3.5. Oncology 13.3.6. Rare Diseases and Orphan Drugs 13.3.7. Pediatrics 13.3.8. Neuroscience 13.3.9. Others 13.4. Country Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 13.4.1. GCC Countries 13.4.2. South Africa 13.4.3. Saudi Arabia 13.4.4. Turkey 13.4.5. Rest of MEA 13.5. Middle East and Africa Pharmaceutical Drug Development Services Market - Opportunity Analysis Index, By Molecule, By Phase, By Specialty Type, and Country, 2019 - 2025 13.6. Middle East and Africa Pharmaceutical Drug Development Services Market Dynamics – Trends
  1. Competition Landscape
14.1. Strategic Dashboard of Top Market Players 14.2. Company Profiles (Introduction, Financial Analysis, Key Developments, Strategies, and SWOT Analysis) 14.2.1. Syneos Health 14.2.2. Parexel 14.2.3. IQVIA 14.2.4. Celerion 14.2.5. Piramal Pharma solutions 14.2.6. Catalent, Inc. 14.2.7. Patheon - a Thermo Fisher Company 14.2.8. Pharmaceutical Product Development, LLC. 14.2.9. Covance Inc. 14.2.10. MEDPACE
  1. Research Methodology
  2. Key Assumptions and Acronyms
  • Syneos Health
  • Parexel
  • IQVIA
  • Celerion
  • Piramal Pharma solutions
  • Catalent, Inc.
  • Patheon – a Thermo Fisher Company
  • Pharmaceutical Product Development, LLC.
  • Covance Inc.
  • MEDPACE